英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
sehen查看　sehen　在百度字典中的解释百度英翻中〔查看〕
sehen查看　sehen　在Google字典中的解释Google英翻中〔查看〕
sehen查看　sehen　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Priovant Therapeutics - clinical-stage biotechnology company
    Priovant Therapeutics is a clinical-stage biotechnology company developing targeted therapies for patients with severe autoimmune disease
  • Priovant Announces FDA Acceptance and Priority Review of New Drug . . .
    Priovant Therapeutics is a biotechnology company dedicated to developing novel therapies for autoimmune diseases with high morbidity and few available treatment options The company's lead asset is brepocitinib, a dual selective inhibitor of TYK2 and JAK1
  • Roivant reports phase 3 autoimmune win for ex-Pfizer asset
    Roivant created Priovant in 2022 after striking a deal with Pfizer for brepocitinib and the TYK2 inhibitor ropsacitinib Brepocitinib moved into phase 3 around the same time, with researchers
  • Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing . . .
    NEW YORK-- (BUSINESS WIRE)-- Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity and mortality
  • Priovant Therapeutics - LinkedIn
    Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens
  • Priovant Therapeutics | | The Pharmaletter
    Priovant develops targeted therapies for severe autoimmune diseases, with current work centered on advancing brepocitinib across late-stage indications where there are limited targeted treatment options and significant patient burden
  • Priovant Overview
    Analysis by Roivant Priovant using closed claims data from Inovalon Analysis includes patients with continuous enrollment from 2020-2022
  • Pfizer and Roivant launch autoimmune specialist Priovant
    The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1 TYK2 inhibitor originated by Pfizer as a treatment for autoimmune
  • Roivant Sciences - Wikipedia
    ^ "Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus" Roivant June 28, 2022 Archived from the original on 2023-03-31 Retrieved 2023-03-31 ^ "Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic
  • Priovant Therapeutics Announces Receipt of Fast Track Designation from . . .
    Priovant Therapeutics is a biotechnology company dedicated to developing novel therapies for autoimmune diseases with high morbidity and few available treatment options The company's lead asset





中文字典-英文字典  2005-2009